- Home
- PLCE vs CLNN Comparison
PLCE vs CLNN Comparison
Compare PLCE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLCE | CLNN |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.0M | 57.4M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLCE | CLNN |
|---|---|---|
| Price | $1.35 | $3.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.20 |
| AVG Volume (30 Days) | ★ 302.3K | 114.2K |
| Earning Date | 09-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $200,000.00 |
| Revenue This Year | N/A | $24.70 |
| Revenue Next Year | $4.75 | $9,228.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.25 | $3.25 |
| 52 Week High | $9.56 | $13.50 |
Technical Indicators
Market Signals| Indicator | PLCE | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 19.37 | 34.55 |
| Support Level | N/A | $3.25 |
| Resistance Level | $2.88 | $4.70 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 3.96 | 1.03 |
Price Performance
Historical ComparisonAbout PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.